Bachet, J. Et Al. 2020. Safety, efficacy and patient-reported outcomes with trifluridine/tipiracil in pretreated metastatic colorectal cancer: results of the PRECONNECT study. ESMO OPEN , vol.5, no.3 .

Bachet, J., Wyrwicz, L., Price, T., Cremolini, C., Phelip, J., Portales, F., ... ÖZET, A.(2020). Safety, efficacy and patient-reported outcomes with trifluridine/tipiracil in pretreated metastatic colorectal cancer: results of the PRECONNECT study. ESMO OPEN , vol.5, no.3.

Bachet, Jean-Baptiste Et Al. "Safety, efficacy and patient-reported outcomes with trifluridine/tipiracil in pretreated metastatic colorectal cancer: results of the PRECONNECT study," ESMO OPEN , vol.5, no.3, 2020

Bachet, Jean-Baptiste Et Al. "Safety, efficacy and patient-reported outcomes with trifluridine/tipiracil in pretreated metastatic colorectal cancer: results of the PRECONNECT study." ESMO OPEN , vol.5, no.3, 2020

Bachet, J. Et Al. (2020) . "Safety, efficacy and patient-reported outcomes with trifluridine/tipiracil in pretreated metastatic colorectal cancer: results of the PRECONNECT study." ESMO OPEN , vol.5, no.3.

@article{article, author={Jean-Baptiste Bachet Et Al. }, title={Safety, efficacy and patient-reported outcomes with trifluridine/tipiracil in pretreated metastatic colorectal cancer: results of the PRECONNECT study}, journal={ESMO OPEN}, year=2020}